E
Elucent Medical
New idea in breast cancer treatment that exists to bring better healthcare ideas
About Elucent Medical
Elucent Medical, Inc. is a medical technology company focused on developing surgical navigation solutions to improve outcomes in oncologic procedures. Founded in 2013 and headquartered in Eden Prairie, Minnesota, the company was established by a team with a successful track record in the med-tech space, including individuals from the former NeuWave Medical. The founding team includes Dr. Lee Wilke, a professor of surgery and director of the UW Health Breast Center; Fred Lee, a professor of imaging science; and Dan Van der Weide, an engineering professor. The impetus for the company came from Dr. Wilke, who identified the need for a more precise and less invasive method for locating tumors during breast-conserving surgery, aiming to replace traditional hook-wire localization techniques.
Elucent Medical operates in the surgical devices market, providing its technology to hospitals and surgical centers. Its business model centers on the sale of its integrated surgical guidance system and the associated disposable components. The company targets surgeons, particularly those specializing in breast cancer, with plans to expand into thoracic and other soft tissue applications. The company has secured significant funding to support its commercialization and development efforts, including a $42.5 million Series C round in April 2024.
The company's core offering is the EnVisio™ Surgical Navigation System, which utilizes In-Body Spatial Intelligence (iSI) to provide real-time, 3D guidance during surgery. This system works in conjunction with the SmartClip®, a permanently implantable, wireless soft tissue marker. The SmartClip can be placed at the time of biopsy to mark a lesion. During surgery, the EnVisio system, which includes a SmartSensor™ that attaches to standard surgical instruments and a SmartSurface™ that generates a spatial field, tracks the SmartClip's location, providing the surgeon with continuous data on the tumor's distance, depth, and direction. This allows for precise navigation to the tumor, aiming to minimize the removal of healthy tissue, reduce the likelihood of needing a second surgery due to positive margins, and eliminate the often uncomfortable pre-surgical hook-wire placement procedure for patients. The system received FDA 510(k) clearance in 2019 and has since been used in thousands of procedures. More recently, the company received an FDA Breakthrough Device Designation for its next-generation EnVisio X1 system, which is in development for broader soft tissue applications, including video- and robotic-assisted surgeries.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| GROWTH EQUITY VCOther financing | Jan 2025 | $30M | — | Trinity Capital | ↗ |
| SERIES COther financing | Apr 2024 | $43M | $170M | Vensana Capital · RC Capital | ↗ |
Growth signals
Latest recorded traffic for Elucent Medical is 4.3K monthly website visits, up 168.8% over the last three months. Elucent Medical's team grew 5.9% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Elucent Medical in the Eden Prairie ecosystem
The Elucent Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Venture Investors Health Fund
Series B and later3 investors entered at this stage
Vensana Capital- RCRC Capital
Trinity Capital
Other known investors2 additional known investors
University of Wisconsin-Madison
WARF Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Elucent Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Elucent Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









